Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion type Assertion NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_head.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion description "[Aberrant methylation of FBN2 was present in 55% (6 of 11) of non-small cell lung cancer (NSCLC) cell lines, but it absent in small cell lung cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion evidence source_evidence_literature NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion SIO_000772 15951052 NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion wasDerivedFrom befree-20150227 NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.
- NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_assertion wasGeneratedBy ECO_0000203 NP396094.RAV8LcrTqUdHZnFc4RXkW_o634zuVdLSL0qnAKcQMCCJg130_provenance.